Thirty-five percent of drugs paid for by Medicare Part B in 2021 were administered in 340B hospital outpatient departments, up from 19% in 2012, new research funded by brand drug manufacturers shows.
The share of Part B drugs administered in
…
Year: 2022
Retail prescription drug spending in the U.S. shot up 7.8% to $378 billion in 2021, more than double the 3.7% spending growth rate in 2020, as the easing of the COVID-19 pandemic brought a surge in doctor visits and a
…
As we reported on deadline on Tuesday, a federal district court ruled this week that Arkansas’ novel 340B antidiscrimination law is not preempted by federal laws governing the 340B program, a decision that strikes down one of two legal arguments
…
The 117th Congress appears destined to end without further action on the 340B program.
The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday,
…
SPONSORED CONTENT
Pop Quiz: Which of these statements are false?
- The United States spends more on health care than any other developed nation. But when compared to 11 other high-income countries, the U.S. ranks last for access to care, health equity, and health outcomes. Case in
The U.S. Health Resources and Services Administration has slightly adjusted the dates of the first of four periods in 2023 during which eligible entities may register themselves, their child sites, and their contract pharmacies to participate in the 340B program.
…
Biopharmaceutical manufacturer Biogen yesterday became the 19th prescription drug company to announce conditions on 340B pricing when covered entities contract with outside pharmacies.
Massachusetts-based Biogen posted a Dec. 12 letter to entities and an accompanying FAQ describing its new
…
A federal district judge ruled yesterday that Arkansas’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the U.S. Food and Drug Administration’s Risk Evaluation and Mitigation Strategies requirements.
U.S. Senior District Judge Billy Roy Wilson’s
…
The Michigan Senate has defeated legislation that hospitals say would have removed language from a nearly year-old state law that stops payers, pharmacy benefit managers, or other third parties from requiring 340B claims modifiers except as required to prevent Medicaid
…
Henry Waxman, a California Democrat who was one of the original sponsors of the 340B law when it was created in 1992, says in a commentary in Health Affairs that criticism of the drug discount program often “reflect[s] a misunderstanding
…